▼ 0.12%
prev close
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. Its key drug is Attruby (acoramidis), an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
Congressional Trades
8
All tracked trades
Members Trading
1
Unique members
Net Activity
+6
7 buys · 1 sells
Members Who Traded This Stock
8 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2026-09-29 | BBIOBridgeBio Pharma, Inc. - Common Stock | Sell | $1,001 - $15,000 | 8d ago | — | |
| 2026-05-11 | BBIOBridgeBio Pharma, Inc. - Common Stock | Buy | $1,001 - $15,000 | 134d ago | — | |
| 2026-04-29 | BBIOBridgeBio Pharma, Inc. - Common Stock | Buy | $1,001 - $15,000 | 165d ago | — | |
| 2026-03-19 | BBIOBridgeBio Pharma, Inc. - Common Stock | Buy | $1,001 - $15,000 | 196d ago | — | |
| 2026-03-18 | BBIOBridgeBio Pharma, Inc. - Common Stock | Buy | $1,001 - $15,000 | 196d ago | — | |
| 2026-03-03 | BBIOBridgeBio Pharma, Inc. - Common Stock | Buy | $1,001 - $15,000 | 196d ago | — | |
| 2025-09-22 | BBIOBridgeBio Pharma, Inc. - Common Stock | Buy | $1,001 - $15,000 | 375d ago | — | |
| 2025-08-08 | BBIOBridgeBio Pharma, Inc. - Common Stock | Buy | $1,001 - $15,000 | 403d ago | — |
2026-09-29
Gilbert Cisneros
BBIO
Amount
$1,001 - $15,000
Filed
8d ago
2026-05-11
Gilbert Cisneros
BBIO
Amount
$1,001 - $15,000
Filed
134d ago
2026-04-29
Gilbert Cisneros
BBIO
Amount
$1,001 - $15,000
Filed
165d ago
2026-03-19
Gilbert Cisneros
BBIO
Amount
$1,001 - $15,000
Filed
196d ago
2026-03-18
Gilbert Cisneros
BBIO
Amount
$1,001 - $15,000
Filed
196d ago
2026-03-03
Gilbert Cisneros
BBIO
Amount
$1,001 - $15,000
Filed
196d ago
2025-09-22
Gilbert Cisneros
BBIO
Amount
$1,001 - $15,000
Filed
375d ago
2025-08-08
Gilbert Cisneros
BBIO
Amount
$1,001 - $15,000
Filed
403d ago
Recent News
Powered by Polygon.io
4 Biotech Stocks With Promising Late-Stage Drug Pipelines to Watch Now
Acoramidis Associated with Significantly Improved Clinical Outcomes Versus Tafamidis in ATTR-CM in an Independent, Real-World Study of U.S. Electronic Health Records
Encaleret Increased Bone Turnover and Improved Participant-Reported Symptoms in the Phase 3 CALIBRATE Trial in ADH1
FDA Grants Priority Review to BridgeBio's Dwarfism Drug Filing
BioMarin Stops Voxzogo Development for Noonan Syndrome
Trade Timeline
Congressional activity, newest first
Gilbert Cisneros
2026-09-29 · Sale
$1,001 - $15,000
Gilbert Cisneros
2026-05-11 · Purchase
$1,001 - $15,000
Gilbert Cisneros
2026-04-29 · Purchase
$1,001 - $15,000
Gilbert Cisneros
2026-03-19 · Purchase
$1,001 - $15,000
Gilbert Cisneros
2026-03-18 · Purchase
$1,001 - $15,000
Gilbert Cisneros
2026-03-03 · Purchase
$1,001 - $15,000
Gilbert Cisneros
2025-09-22 · Purchase
$1,001 - $15,000
Gilbert Cisneros
2025-08-08 · Purchase
$1,001 - $15,000